RE:RE:RE:Also Back InIf the whole sector hadn't been ubiquitously hammered, I'd throw some powder in other directions, but I think investors are looking for catalysts now, and as far as I know, POZN/TRX has a chance of being first to that table with the merger. I have to do some more research on that CXR bought financing deal as the market *really* didn't like it. Grwoth by acquisition seems to be falling out of favor compared with organic growth which is why I wouldn't mind seeing TRX standalone again. Merus is still a dog in my opinion. I bought a bunch of shares at $1.70 over a year ago (before selling them) but wouldn't have made a nickel in all that time. I think Fishman has said expect 0 organic growth for the next 2 years - not something I like to hear. Horizon is probabaly a deal at these levesl, but investors are scared about their high priced drugs.